BioGend Therapeutics Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 1.393 million compared to TWD 1.461 million a year ago. Operating loss was TWD 133.615 million compared to TWD 167.113 million a year ago. Net loss was TWD 145.594 million compared to TWD 162.903 million a year ago. Basic loss per share was TWD 1.67 compared to TWD 2.01 a year ago.